Skip to content

Registry Study of Clinical Application of MRI Compatible CIED

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02380300
Enrollment
2067
Registered
2015-03-05
Start date
2015-03-15
Completion date
2020-09-30
Last updated
2022-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Need for MRI Imaging With Pacemaker or Implantable Cardioverter Defibrillator Implanted

Brief summary

The purpose of this study is to clear the Safety and Necessity of the Magnetic Resonance Imaging (MRI) in the Presence of CIEDs(Cardiovascular Implantable Electronic Devices).

Interventions

None listed

Sponsors

Biotronik (Beijing) Medical Device Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Inclusion criteria * Patient is \>18 years old * Patient implanted with a Biotronik MRI compatible CIED (including the pacemaker, cardiac resynchronization therapy, implantable cardioverter defibrillator, and cardiac resynchronization therapy-defibrillator) in the past two months * Patient has provided a written informed consent * Patient's height is≥140cm 2.

Exclusion criteria

* Have other medical implants that may interact with MRI, e.g. abandoned pacemaker/ICD leads, lead extensions, mechanical valves, other active medical devices, non-MRI compatible devices * Life expectancy less than 2 years * Pregnant and/or breat-feeding females or females who intend to become pregnant in next two years * Patient is currently participating in another study * In the investigator's opinion patient will not be able to comply with the follow-up requirements

Design outcomes

Primary

MeasureTime frame
Serious adverse eventstwo years
The raise of Impedance Threshold of the Atrial and Ventricleimmediate;one month
RA sensing amplitude (daily mean): < 1.5 mV or RV sensing amplitude (daily min.): < 2.0 mVimmediate;one month
The proportion of patients with CIED who need MRI examinationtwo years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026